Matthew Porteus
Geen lopende functies
Vermogen: 8 M $ op 31-05-2024
Actieve functies van Matthew Porteus
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Stanford School of Medicine | Corporate Officer/Principal | 01-10-2010 | - |
| Stanford University | Corporate Officer/Principal | - | - |
Loopbaan van Matthew Porteus
Eerdere bekende functies van Matthew Porteus
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | 01-02-2003 | 01-08-2010 |
| LENZ THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-03-2020 | - |
| Oprichter | 01-06-2017 | - | |
| CRISPR THERAPEUTICS AG | Oprichter | 31-10-2013 | - |
Opleiding van Matthew Porteus
| Harvard University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Zwitserland | 2 |
Operationeel
| Founder | 3 |
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Matthew Porteus
- Ervaring
